Pegylated liposomal doxorubicin hydrochloride
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Pegylated liposomal doxorubicin hydrochloride, covering 2014-12-25 to 2023-03-29. Get the full timeline:
Most recent: Clinical Trial Update: Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer [Phase 2]